Adalimumab Biosimilars: A New Era in Accessible Healthcare Solutions
However, its high cost has driven the development of biosimilars, offering cost-effective alternatives without compromising on efficacy. This article explores the impact, market dynamics, and future potential of adalimumab biosimilars.
